At the age of 98, Patrick Fay had been fortunate to lead a full and relatively healthy life. Except for the usual challenges that come with aging, he had no significant health issues. Which is why he was surprised when, during a routine appointment with his dermatologist, concerning lesions were discovered on his legs. Referred to Smilow Cancer Hospital, Mr. Fay saw Kelly Olino, MD, assistant professor of surgery (oncology) and underwent a biopsy that revealed stage III melanoma.
Dr. Olino, a surgical oncologist with additional training in cancer immunotherapy, treats patients affected by skin cancer. "I see a wide variety of people because skin cancer affects everybody, no matter their age, unfortunately," says Dr. Olino, who also serves as leader of skin cancer surgery for the Melanoma Program and is clinical director of the Smilow Melanoma Program.
Although no cancer diagnosis is uneventful or straightforward, Mr. Fay, who recently celebrated his 102nd birthday, commented that overall, his experience has been a positive one. His son Paul, one of Mr. Fay’s primary caretakers, explained that they made the decision to start his father on Keytruda, an immunotherapy that works to treat advanced melanoma by blocking a protein called PD-1 on immune cells, allowing them to more effectively recognize and attack cancer cells.
Under the guidance of Thuy Tran, MD, PhD, assistant professor of medicine (medical oncology and hematology), he started treatment with Keytruda in 2021 and in 2023 switched to another immunotherapy treatment known as Opdivo in the hopes of keeping the cancer from spreading. He receives the treatment once a month at Smilow Cancer Hospital in Guilford.
“There have been some increased lesions on his leg, but there has been no spread of the cancer to other parts of his body in four years,” explains Paul. “We had heard of immunotherapy in vague terms, but didn’t fully understand how it was being used in melanoma. At the age of 98, it seemed like the least intrusive approach to take for my father. Fortunately, he hasn’t experienced any of the side effects which, honestly, were not that alarming considering the alternative.”
A diagnosis of any cancer at any age can be traumatizing for a patient and their family, and Mr. Fay’s was made more so as it came one month after the loss of his wife of 76 years. “Together we had six children, 10 grandchildren, and 19 great grandchildren. It was very hard to take in and accept this diagnosis so soon after losing my wife.”